GRMA 2022 Summit Agenda

Environmental contaminants, either man-made or naturally occurring, can pose a risk to agricultural product safety and a threat to consumer health by their persistent presence in soil, sediment, and groundwater. Per- and Polyfluoroalkyl Substances (PFAS) and toxic elements (heavy metals) are two such environmentally ubiquitous, bio- accumulative classes of contaminants in agricultural products that continue to draw the attention of regulators and public health officials alike. As with all such traded commodities, data confidence for risk assessments; surveillance and compliance programs; and internal GMP practices is heavily dependent on validated, fit-for-purpose compendial methods that are based on consensus-driven performance standards. PFAS and toxic element contaminants, however, present unique analytical challenges based on their chemistry, affected matrices, and potential toxic exposure among subsets of the population. This presentation will offer insights into the public health threat each presents, the existing gaps in testing capabilities, and the role analytical standards and methods development must play in ensuring product integrity and safety.

This presentation will discuss FDA’s current priorities for dietary supplements and address current challenges facing the agency in regulating the $50 billion dollar market. It is critical that FDA work with stakeholders in industry, academia, and government to achieve the primary goal of protecting public health and ensuring a safe and high-quality marketplace: where are the gaps in the current approach and what are the opportunities for advancing these goals.

• How will FDA conduct inspections of domestic and foreign dietary supplement manufactures subject to 21CFR111 within mandated FSMA inspection frequencies and enforcement
• How will FDA collect and analyze domestic and import samples to determine compliance with requirements of FD&CA
• How will FDA enforce dietary supplement regulations for products that are not in compliance with FDA&CA including Corrective actions, verification and follow up inspections and investigations
• How will FDA collect information to determine if dietary supplements are being labeled in accordance with applicable requirements
• How will FDA collect compliance information for FDA to modify or develop enforcement strategies

• Upcoming Strategic Planning
• Updates on Key Programs

This learning session will delve into key aspects of cosmetic regulation and certification, including the importance of GMP best practices, requirements for NSF/ANSI 455-3, top non-conformances and creating a culture of compliance.

With the constantly evolving Hemp and Cannabis Industry what has the industry come together on?  What are the biggest questions still facing the industry with it comes to safety, pesticides, chain of custody, testing, regulatory, and marketing of products?  Hear from industry leaders on the status of the GRMA CBD taskforce as they discuss achievements, lessons learned, and look at the remaining challenges.

Panelists:

• Adora Parker – Director of Quality Assurance & Regulatory Compliance Dollar Tree / Family Dollar & GRMA Governance Board Director
• Jennifer Knaack – VP of Compliance & Science, Cheef Holdings
• Brett Goldman – Partner, O’Can Group
• Joe Lillis – Cannabis Quality, Safety and Risk Specialists, UL
• David McPherson – Director Food Safety & Regulatory Compliance, The Kroger Co, Vitacost
• Reed Doyle – Robertet USA

With strong demand and forecasted double digit growth for Vegan products around the globe in the upcoming years how well do you know your Vegan products and program?  BeVeg’s global trademark program is the only attorney drafted and accredited program in the industry and serves Dietary Supplements, Pharmaceutical, and Cosmetic products amongst other categories.  Learn about the program advantages and synergy with the GRMA’s certification program.

Are you maximizing your membership? Do you have questions for the GRMA? Are there topics or areas of harmonization that you’d like to see addressed? Committees or working groups that should be form?  This session is for you.

Dietary supplement manufacturer and brand owners have an ever-critical responsibility to ensure that the finished products entering the market are high quality and safe for consumption. More and more products are entering the market and the increase in the demand for these products are high. With a low barrier to entry and no up-front safety data needed to sell products through multiple retail and online channels creates a safety risk to the consumer. To establish consumer confidence and to do things the right way, it is up to the brand owners to have a rugged and comprehensive quality testing program throughout the life cycle of the manufacturing process and reduce the risk of possible contamination. This presentation will focus on some key aspects to designing a comprehensive analytical testing program to ensure the safety and quality of their products entering the market.

With regulatory action on product claims, compliance findings, and more being an evolving expectation within the health and wellness category, what pressures are being placed on retailers, brands, and manufacturers when it comes to product claims and integrity?

This panel will feature members of the Dietary Supplement Product Integrity Committee (DSPIC) as they discuss:

• Incorporation of AOAC Standard Method Performance Requirements into the committee’s harmonization goals and objectives.
• Definition of Product Integrity
• Upcoming challenges & desired state

Panelists Include:

• Jeff Brams – Chief Innovation Officer, Garden of Life & GRMA Governance Board Director
• David McPherson – Director Food Safety & Regulatory Compliance, The Kroger Co, Vitacost
• Mohamad Koroma – Director of R&D, Pharmavite
• Duffy MacKay – Sr. VP of Dietary Supplements, CHPA
• Petra Erlandson – Director Sales & Marketing, Alkemist Labs

See who is honored for their contributions to the GRMA over the past year